Stockreport

Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry [CNBC]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Top executives from drugmakers of all sizes met with investors to map out their plans for 2026 and beyond. Big pharma is grappling with the impact of new drug pricing [Read more]